Daptomycin (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Daptomycin drug offered from Fresenius Kabi USA, LLC. This Lipopeptide Antibacterial [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | Daptomycin |
| SUBSTANCE NAME: | DAPTOMYCIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Lipopeptide Antibacterial [EPC],Lipopeptides [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-06-28 |
| END MARKETING DATE: | 0000-00-00 |
Daptomycin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Daptomycin from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 500(mg/10mL) |
| START MARKETING DATE: | 2016-06-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-871_dc7e3d25-8de1-4a96-aa08-ae2d2ebbe8f7 |
| PRODUCT NDC: | 63323-871 |
| APPLICATION NUMBER: | ANDA206005 |
Other DAPTOMYCIN Pharmaceutical Manufacturers / Labelers:
